G

Genomictree Inc
KOSDAQ:228760

Watchlist Manager
Genomictree Inc
KOSDAQ:228760
Watchlist
Price: 27 300 KRW 1.11% Market Closed
Market Cap: 665.6B KRW

Wall Street
Price Targets

Price Targets Summary
Genomictree Inc

There are no price targets for Genomictree Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomictree Inc Competitors:
Price Targets
DVYSR
Devyser Diagnostics AB
48% Upside
ZYME
Zymeworks Inc
36% Upside
4974
Takara Bio Inc
37% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
12% Upside
EVAX
Evaxion Biotech A/S
156% Upside
ALKS
Alkermes Plc
60% Upside
VYGR
Voyager Therapeutics Inc
279% Upside
GNFT
Genfit SA
66% Upside

Revenue
Forecast

Revenue Estimate
Genomictree Inc

For the last 8 years the compound annual growth rate for Genomictree Inc's revenue is 20%. The projected CAGR for the next 2 years is 83%.

20%
Past Growth
83%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genomictree Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Genomictree Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Genomictree Inc's stock price target?
Not Available

Genomictree Inc doesn't have any price targets made by Wall Street professionals.

What is Genomictree Inc's Revenue forecast?
Projected CAGR
83%

For the last 8 years the compound annual growth rate for Genomictree Inc's revenue is 20%. The projected CAGR for the next 2 years is 83%.

Back to Top